Elanco动物保健公司抗IL-31单抗注射液Befrena™(Tirnovetmab)获美国农业部批准,靶向治疗犬过敏性及特应性皮炎

美股速递
Jan 01

美国农业部已正式批准Elanco动物保健公司的新型抗IL-31单克隆抗体注射液Befrena™(Tirnovetmab)上市。该创新疗法专门用于治疗犬类的过敏性皮炎和特应性皮炎。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10